期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
益气养阴活血通络方对糖尿病肾病患者糖、脂代谢及血流变的影响 被引量:25
1
作者 白璐 张江华 +2 位作者 张晋升 唐立伟 霍贝贝 《河北中医药学报》 2016年第3期9-11,共3页
目的:基于中医学"同病异治"理论,探讨益气养阴活血通络方对糖尿病肾病患者不同分期证型间糖、脂代谢及血流变的影响。方法:120例糖尿病肾病患者随机分为对照组及研究组各60例,对照组予厄贝沙坦片口服治疗,研究组在此基础上辨... 目的:基于中医学"同病异治"理论,探讨益气养阴活血通络方对糖尿病肾病患者不同分期证型间糖、脂代谢及血流变的影响。方法:120例糖尿病肾病患者随机分为对照组及研究组各60例,对照组予厄贝沙坦片口服治疗,研究组在此基础上辨证加用中药口服,治疗3个月,比较两组治疗前后及两组之间空腹血糖、血脂、血流变的变化。结果:与本组治疗前比较,对照组甘油三酯、全血黏度高切变率(200/s)、血浆黏度水平明显降低(P<0.05);研究组空腹血糖、血脂、全血黏度及血浆黏度均明显降低(P<0.05),且效果优于对照组(P<0.05)。结论:益气养阴活血通络方可以明显改善糖尿病肾病患者糖、脂代谢紊乱,改善血液的高黏高凝状态,临床疗效确切。 展开更多
关键词 益气养阴活血通络方 水肿 糖尿病肾病 血糖 血脂 血流变 厄贝沙坦片
下载PDF
Association of NFkB1 Gene Polymorphism with Inflammatory Markers in Patients of Type 2 Diabetes Mellitus with or without Renal Involvement in Eastern India
2
作者 Sonalika Behera Andrew Abel Lamare +2 位作者 Roma Rattan Bijan Patnaik Sidhartha Das 《Journal of Diabetes Mellitus》 2020年第3期169-181,共13页
<strong>Aims: </strong>To evaluate the association of Nuclear factor kappa B1(NFkB1) gene polymorphism with inflammatory markers Urinary Monocyte Chemoattractant Protein 1 (UMCP1) and Tumor Necrosis Factor... <strong>Aims: </strong>To evaluate the association of Nuclear factor kappa B1(NFkB1) gene polymorphism with inflammatory markers Urinary Monocyte Chemoattractant Protein 1 (UMCP1) and Tumor Necrosis Factor alfa (TNF alfa) in Patients of diabetes mellitus with or without renal involvement in Eastern India. <strong>Material and Methods: </strong>Consecutive Patients of Type 2 Diabetes Mellitus (DM) with or without microalbuminuria attending SCB MEDICAL COLLEGE and HOSPITAL Medical OPDs in between September 2018 to September 2019 were recruited in this study. Patients were subjected to blood and urine investigations. DNA extraction and Restriction fragment Length Polymorphism (RFLP) was done in Department of Biochemistry. Controls were unrelated healthy attendants with no history of Diabetes Mellitus, HTN, Chronic Kidney Disease (CKD). <strong>Results:</strong> Mean Systolic BP, Fasting Blood Glucose, Post Prandial Blood Glucose, HBA1c, Total Cholesterol were significantly higher in diabetes mellitus and diabetic nephropathy groups than control group. Estimated Glomerular Filtration Rate was significantly lower in diabetic nephropathy (p value < 0.001). UMCP1, Urinary Albumin Creatinine Ratio, TNF alfa were higher in diabetes mellitus and nephropathy with p value (<0.001, 0.006 < 0.001) respectively. In between DM and Diabetic Nephropathy groups nfkb1 gene expression, umcp1 and tnf alfa levels were significantly increased in Diabetic nephropathy with p value 0.019, <0.01, 0.001 respectively. Insertion/insertion NFkB1 gene polymorphisms were more in diabetic nephropathy group and were positively correlated with inflammatory markers UMCP1 (r = 0.517, p < 0.01) and TNF alfa (r = 0.172, p = 0.19). <strong>Conclusion:</strong> insertion/insertion NFkB1 gene polymorphism increases the risk of nephropathy by 2.52 times (OR = 2.52, 95% CI: 0.04 - 0.63, p value = 0.019) in diabetes patients in eastern India. 展开更多
关键词 dn: diabetic nephropathy UACR: Urinary Albumin Creatinine Ratio UMCP1: Urinary Monocyte Chemoattractant Protein 1 TNF Alfa: Tumor Necrosis Factor Alfa NFkB1: Nuclear Factor Kappa B Ins/Ins Polymorphism: Insertion/Insertion Polymorphism Del/Del Polymorphism: Deletion/Deletion Polymorphism Ins/Del Polymorphism: Insertion/Deletion Polymorphism
下载PDF
前列地尔联合丹红注射液治疗早期糖尿病肾病疗效观察 被引量:2
3
作者 刘青员 朱静和 +1 位作者 李冬玲 蒋凤 《基层医学论坛》 2016年第29期4045-4046,共2页
目的观察前列地尔联合丹红注射液治疗早期糖尿病肾病的临床效果。方法将67例早期糖尿病肾病患者随机分为3组,常规组22例行常规治疗,前列地尔组21例为前列地尔注射液加常规治疗,联合组24例为前列地尔与丹红注射液加常规治疗。疗程2周,并... 目的观察前列地尔联合丹红注射液治疗早期糖尿病肾病的临床效果。方法将67例早期糖尿病肾病患者随机分为3组,常规组22例行常规治疗,前列地尔组21例为前列地尔注射液加常规治疗,联合组24例为前列地尔与丹红注射液加常规治疗。疗程2周,并监测尿微量白蛋白、β2微球蛋白、血尿素氮、肌酐。结果前列地尔组及联合治疗组尿微量白蛋白、β2微球蛋白在治疗后明显下降,与常规治疗组比较差异有统计学意义(P<0.01);联合组与前列地尔组比较,差异有统计学意义(P<0.01)。结论前列地尔联用丹红注射液可明显降低早期糖尿病肾病患者的尿白蛋白,防止病情进展。 展开更多
关键词 糖尿病肾病 前列地尔 丹红注射液 尿白蛋白
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部